Disclosures for "Decreased Timing to Vasospasm Prevention Medication Improves Outcomes Among Patients with Aneurysmal Subarachnoid Hemorrhage on Prehospital CCBs, ARBs, or ACE-inhibitors")
-
Donald Frei has received personal compensation in the range of $0-$499 for serving as a Consultant for Philips. Donald Frei has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stryker. Donald Frei has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens. Donald Frei has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Shape Memory Medical. Donald Frei has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genentech. Donald Frei has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Stryker. Donald Frei has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Penumbra. Donald Frei has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Viz.AI. Donald Frei has received stock or an ownership interest from Penumbra. Donald Frei has received research support from Penumbra.
-
Stephanie Jarvis has nothing to disclose.
-
Dr. Pirahanchi has nothing to disclose.
-
Dr. DiSalvo has nothing to disclose.
-
Mr. Wenz has nothing to disclose.
-
David Bar-Or has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Ampio Pharmaceuticals. David Bar-Or has stock in Ampio Pharmaceuticals.